GSK opens new state of the art respiratory manufacturing facility in ...
WEBGSK today opens a £56 million state of the art manufacturing facility, creating 150 new jobs in the UK, in response to demand for GSK’s portfolio of respiratory medicines delivered by the innovative Ellipta inhaler.
R&D locations - GSK
WEBGSK Jurong is a mixed Global Supply Chain and R&D site. It features clinical and development small molecule manufacturing. Our Tres Cantos site, where medicines have been discovered and developed for over 25 years, is focused on discovering new therapeutics to prevent infectious diseases.
Home - Riverlabs
WEBWare is an established life sciences location having been a strategic R&D location for GSK for over 50 years. The town is already home to thousands of research scientists and Hertfordshire as a whole has a significant talent pools to recruit from and is home to 33,847 scientists, 17,924 production operatives and 30,645 laboratory specialists.
Locations - GSK
WEBLearn more about GSK around the world by visiting our market websites listed out below. For contact information including product information websites for healthcare professionals, visit our Worldwide directory. Our market company websites and web pages are intended for non-UK audiences.
GSK opens state-of-the-art respiratory manufacturing facility in Ware…
WEBApr 29, 2016 · GSK has opened a UK£56m state-of-the-art manufacturing facility, creating 150 new jobs in the UK, in response to demand for GSK’s portfolio of respiratory medicines delivered by the innovative Ellipta inhaler.
GSK opens £56m respiratory medicines production plant in UK
WEBApr 18, 2016 · GlaxoSmithKline (GSK) has expanded its respiratory medicines production capacity with the opening of a new £56m manufacturing facility in Ware, UK. More than £100m was invested in the new facility over the past five years, which has been built to cater to the demand of GSK’s respiratory medicines delivered by Ellipta inhaler.
GSK pumping out millions more Ellipta inhalers with new U.K.
WEBApr 20, 2016 · The U.K. drugmaker ($GSK) opened an $80.5 million (£56 million), 4,500-square-meter plant this week in Ware, U.K. The 48,437-square-foot expansion will allow the Ware site to nearly double...
GSK pumps £200M+ into UK manufacturing network to bolster …
WEBJan 16, 2024 · Further, GSK is poised to kick off production at its £65 million ($82 million) site in Ware, England, which opened in September. The Ware site represents a global manufacturing location...
Location - Riverlabs
WEBWare is an established life sciences location having been a strategic R&D location for GSK for over 50 years. So not only does it have a legacy of science, it also has a huge pool of talent that call it home. It’s also a beautiful, thriving place to live and work. Benefits of Ware. Local talent pool.
GlaxoSmithKline opens new $56.6M vaccines plant in Scotland
WEBAug 15, 2017 · GlaxoSmithKline opened its new $56.6 million vaccines plant in Montrose, Scotland, that will manufacture sterile aluminum salts and includes a microbiology lab.
- Some results have been removed
Skip to content